IPO Discussion Page

Please Note: All views and opinions expressed in reader comments are solely those of the individual submitting the comment, and not those of the or its staff.


Close VALUE INVESTOR's Comments


39. VALUE INVESTOR  Jul 28, 2016 3:09:30 PM IST Reply

Advanced Enzyme Technologies Ltd IPO

Status available on website now
38. VALUE INVESTOR  Jul 22, 2016 11:03:54 AM IST Reply

Advanced Enzyme Technologies Ltd IPO

GMP down from 400 Rs to 318 - 320 Rs due to global market volatility.
37. VALUE INVESTOR  Jul 21, 2016 6:13:11 PM IST Reply

L&T Infotech Ltd IPO

Flat and muted listed as expected like L&T Finance
May go down after trapping more people at higher levels
good buy around 600-625 Rs as all IT stocks are down.
Waste IPO after postponing it so many times and pricing it higher.
Greedy management, Good lesson.
37.1. Bharat Ahuja  Jul 22, 2016 1:46:29 AM IST

L&T Infotech Ltd IPO

Management did not learnt any lesson. Its poor retail who learnt lesson again after LTFin that this management is super greedy and wont leave a penny for retail.
Boycott their next ipo of L&T technology
36. VALUE INVESTOR  Jul 19, 2016 6:00:31 PM IST Reply

L&T Infotech Ltd IPO

Got 1 out of 4, same as QUESS!!!! Relieved that i did not get alloted in the other accounts for the first time :-)
35. VALUE INVESTOR  Jul 19, 2016 9:28:13 AM IST Reply

Advanced Enzyme Technologies Ltd IPO

Analysis of upcoming IPO of Advanced Enzyme Technologies has been loaded on LinkExternal Link

You can access it in the Free Zone in New Issue Analysis section (no login required). The section can be accessed at:

New issue (IPO) Analysis of Advanced Enzyme Technologies
Onward and Upward …

Advanced Enzyme Technologies is entering primary market on Wednesday 20th July, 2016, to raise Rs. 50 crore via fresh issue of equity shares of Rs. 10 each and an Offer For Sale (OFS) of upto 40.35 lakh equity shares, both in the price band of Rs. 880-896. Issue size aggregates to Rs. 411.5 crore at the upper end of the price band, of which, OFS portion is of Rs. 361.5 crore. Representing 20.6% of the post issue paid up capital at the upper end, issue closes on Friday 22nd July, 2016.

Advanced Enzyme Technologies is the largest enzyme company in India, with fermentation capacity of 360 cubic meters and has the second highest market share domestically, next only to the world''s largest enzyme company Novozymes. Having 6 manufacturing facilities (4 in India and 2 in California) and 4 R&D facilities (3 in India and 1 California), company (along with its subsidiary) has 13 patents and 172 trademarks registered in its name, with 4 patents and 14 trademarks pending before relevant authorities.

Advance Enzyme operates through two segments viz., Healthcare & Nutrition segment (79.72% of total revenue in FY16) and Bio-Processing (20.28% of total revenue in FY16). Geographically, US is important focus market for the company, which contributed nearly 55% of revenue in FY16, followed by India, accounting for 36% revenue, while rest is made up by Europe and other geographies. Company having global clientele of more than 700 customers, generated nearly 42% of total revenue from top 10 clients.

Having presented the background of the company, let us take a look at its financial performance.

In FY16, company’s total income rose to Rs. 295 crore, from Rs. 224 crore in FY15, representing growth of 32% over FY15. EBITDA rose to Rs. 139 crore from Rs. 92 crore in FY15, with margin expanding to 47.2% from 41% seen in FY15. This resulted in PAT (after minority interest) of Rs. 78.4 crore, against Rs. 50.1 crore seen in FY15, registering stupendous growth of 56.6%, leading to an EPS of Rs. 36.03 for FY16.

Over the past 5 years (FY11-FY16), company’s total income has grown at a CAGR of 14%, while PAT has registered healthy CAGR of 23.9.

As on 31-03-2016, equity stood at Rs. 21.77 crore, while Net Worth was at Rs. 278.73 crore. Company has been focused on de-leveraging its balance-sheet consistently, and as a result, consolidated debt has come down from Rs. 175 crore in FY11 to Rs. 69 crore as on 31-03-2016, representing healthy cash flow generation by the company. Currently it has Cash & Cash Equivalents of Rs. 26 crore and Inventory of Rs. 60 crore. Promoters are holding 80.53% stake in the company, which will reduce to 66.5% post IPO.

At the upper end of the price band, company is seeking market cap of Rs. 2,000 crore and EV of Rs. 2,043 crores. This leads to EV/EBITDA multiple of 15x and 12x for FY16 and FY17 respectively, and PE multiple of 25x and 21x for FY16 and FY17 respectively. Also, let us re-iterate here that company has robust EBITDA margin of 47.2% and delivered Return of Net Worth of 28.14% in FY16 with lean balance-sheet.

In the absence of directly listed peer domestically, we compared Advanced Enzymes with Novozymes, world leader in industrial enzymes with market share of 48%, which is currently trading at PE multiple of 33x. This is at 57% premium to PE multiple of Advanced Enzyme Technologies (at the upper end of the price band). On a comparative basis, with premium for leadership status and scale of operations having given to Novozymes, the valuations of Advanced Enzymes is seen reasonable, given good return ratios and better margins, coupled with lean balance-sheet.

Going ahead, global enzyme demand is expected to be led by speciality enzymes, including diagnostic, research & biotechnology enzymes, bio-catalysts and increasing penetration of enzymes into their potential applications in developing countries. Also, company has deep roots in US, the largest consumer of enzymes in the world. Also, the wide spectrum of user industry including human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, textile, paper etc gives comfort on earnings visibility and demand growth.

To conclude, issue is seen reasonably priced, with scope for capital appreciation and listing gains seen as well valued attractively and investment is advised.

Disclosure: No Interest
34. VALUE INVESTOR  Jul 19, 2016 9:14:43 AM IST Reply
33. VALUE INVESTOR  Jul 18, 2016 8:51:54 PM IST Reply

L&T Infotech Ltd IPO

LinkExternal Link

Some good news to cheer before listing !!!!!
L&T Infotech bags contract for Project Insight
The project, worth about Rs 1,000 crore, will use technology to allow the government to collate all information available with the I-T department and profile people using Permanent Account Number (PAN) detail

32. VALUE INVESTOR  Jul 16, 2016 10:17:59 AM IST Reply

L&T Infotech Ltd IPO

Some people who have not applied simply floating with messages of L&T infotech.

Bhai log, sabar karo, pehele allotment to anne do, phir listing ka sochenge.
Aur, phir jin logene apply hi nahi kiya, shanti se raho, discount listing hoga to hum dekh lege. Chinta maat karo, 20 si share hain na, koi 100 share toh nahi hain!!!!
31. VALUE INVESTOR  Jul 15, 2016 9:26:07 AM IST Reply

Quess Corp Ltd IPO

MGL is more like precision camshaft, you money will
go into gestation period for long and it will get stuck.
Better to invest in stock which fetch you money fast and at the
sametime take advantage of bullish market. Just my opinion.
31.1. gamble  Jul 15, 2016 10:18:58 AM IST

Quess Corp Ltd IPO

NIi 0.73x
Qib 2.62x

Nii 191x
Qib 72x

Do u see any difference??


I hv pre cam @150 @140 @130 waiting for buy at 120,110,100...
Mgl @506 ...waiting for buy 490,480,470....

31.2. VALUE INVESTOR  Jul 15, 2016 1:40:27 PM IST

Quess Corp Ltd IPO

gamble ji, just because you bought MGL at 502, you are asking to buy MGL.
Its your choice.

I had purchased again today quess 50@481, it is doing well at 494.
so i have 100@469, after i had sold allotted 45@487 on listing day.

I had confidence in MGL and did not sell on listing day and sold last week 105@506. after which it went to 492 before recovering to 490 today.

All i am saying is there are some stocks like dominos pizza if you remember, it was issued at 135 Rs listed at 192 and i kept watching it going to 1200 Rs without entering thinking it is too high a price for me to enter. But it went up daily.

All i am saying is if you are confident on a stock hold it. I never built a portfolio and always been a flipper mostly in primary market as i have a full time job and can''t spend time on this. But now, i have decided to keep some stocks for longterm and build one.

Some turn out to be winners and some turn out to be losers, but you need to balance and ensure that you are in positive in terms of money invested, otherwise you will lose your sleep and peace over it.

31.3. gamble  Jul 15, 2016 2:29:43 PM IST

Quess Corp Ltd IPO

Yes u r thinking that is okay btw u should have proud of ur own way of thinking...yes i choose mgl over quess because i found mgl can correct less compare to quess,,,i do not bother if my holding goes down,i just add it on every fall ...i will do same with mgl if i got chance at lower level...

Everyone have to confident for their buying/holding stock...if u believe that it can go up then it will...:)
30. VALUE INVESTOR  Jul 14, 2016 8:17:00 PM IST Reply

Quess Corp Ltd IPO

Quess will be better performer compared to MGL.
Where there are more delivery volumes, chances of shares going up are very less
are floating shares are less!!!!
30.1. gamble  Jul 14, 2016 8:49:31 PM IST

Quess Corp Ltd IPO

May b ur right..quess can show better short(which i donno believe)


Quess corp is worth to buy at this rate?
Mgl is worth to buy at this rate?

Ask urself!!
30.2. Eagleye  Jul 27, 2016 10:14:04 AM IST

Quess Corp Ltd IPO

I Completely agree
29. VALUE INVESTOR  Jul 14, 2016 2:46:48 PM IST Reply

Quess Corp Ltd IPO

superb pullback from 452 to 482 today, momentum is there.
I purchased 50@459. Enjoying the wave....till it lasts.
28. VALUE INVESTOR  Jul 14, 2016 2:41:08 PM IST Reply

Quess Corp Ltd IPO

quess trading at 480 now sudden jump from 460 to 482 Rs.
27. VALUE INVESTOR  Jul 13, 2016 7:26:00 PM IST Reply

L&T Infotech Ltd IPO

No chance of firm allotment in retail. May be 1 in 4 will get allotment.
Nothing to worry.
27.1. Sunil Patel  Jul 13, 2016 7:34:23 PM IST

L&T Infotech Ltd IPO

1:4 most likely. Now people will think before applying after this IPO
26. VALUE INVESTOR  Jul 13, 2016 7:52:33 AM IST Reply

L&T Infotech Ltd IPO

Expect atleast 11-13 times in retail
26.1. Anirudh Bhargava  Jul 13, 2016 10:54:16 AM IST

L&T Infotech Ltd IPO

25. VALUE INVESTOR  Jul 12, 2016 10:06:02 AM IST Reply

Quess Corp Ltd IPO

sold 45@487, don''t want to speculate.
24. VALUE INVESTOR  Jul 11, 2016 8:26:23 PM IST Reply

Quess Corp Ltd IPO

Market price: See at 9:45 AM
Rest depends on the traders :-)
23. VALUE INVESTOR  Jul 8, 2016 8:18:35 PM IST Reply

Mahanagar Gas Limited IPO

Good buy around 470-475. Movement of these stocks spurt on news otherwise mostly dormant. Even indraprastha gas and GAIL are falling. I made the mistake of not selling on listing day. Sold alloted 105@506 yesterday. Better to make away with whatever you get rather than waiting and losing more and more.
22. VALUE INVESTOR  Jul 8, 2016 8:10:11 PM IST Reply

Advanced Enzyme Technologies Ltd IPO

This is a portfolio stock and first stock of its type in the segment.
The potential of this stock is limitless in long term and issue size is very
small. If you get allotment, sell some on listing gains and hold rest for long term.
22.1. Banker  Jul 8, 2016 10:47:51 PM IST

Advanced Enzyme Technologies Ltd IPO

Kya baat hai investor ji ek to 10-15 shares allot honge usme se bhi kuch listing me nikaal do baaki long term holding
22.2. Gravitas  Jul 9, 2016 3:25:43 AM IST
21. VALUE INVESTOR  Jul 8, 2016 7:53:02 PM IST Reply

Quess Corp Ltd IPO

They have got a new building in bellandur , bangalore and whole building is occupied by only quess. It operates worldwide with employess of 1,20,000 people, strong promoter background and only listed peer is teamlease which is already trading around Rs 1200.
20. VALUE INVESTOR  Jul 8, 2016 7:47:55 PM IST Reply

Quess Corp Ltd IPO

ISSUE SIZE is too small and GMP will hold for quess. No doubts about it as the issue is priced attractively, Few new prodigies have propped up on this board creating doubts for the allotees.
By Popular Stock Brokers

SAS Online Stock Trading, Demat, Brokerage and Reviews  SAS Online

Rs 999 for Unlimited Trading

Get Free Trading Account

Zerodha  Zerodha

Free Equity Delivery Trades
Flat Rs 20 Per Trade for F&O

Rs 100 off on account opening* + 100% brokerage refund if in 60 days you have made net profits

Enquire Now
(* on online account opening)

Trade Smart Online (TSO)  Trade Smart Online

Flat Rs 15 Per Trade

100% cash back on 30 days brokerage (up to Rs 1000)

Get This Exclusive Offer


Brokerage: Intraday @ 0.02%, Delivery @ 0.15%

Rs 0 account opening fee
(Rs 400 waived)

Request Demo


Beginner, seasoned investor, active trader or HNI. Get customised solutions.

Rs 0 account opening fee on Online Trading and a Demat Account
(Rs 1150 waived)

Request Call Back

More About Brokers

Special Offers Broker Reports

Message Board

Discussion Forum